Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Phio Pharmaceuticals Corp.

Get SEC filing alerts via email and in your feed for Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

About Phio Pharmaceuticals Corp.

Phio Pharmaceuticals is a clinical-stage biotech company developing immuno-oncology therapeutics using its proprietary INTASYL RNA interference technology. Its focus is on creating targeted cancer treatments that enhance immune cell effectiveness without complex delivery systems. The company’s pipeline includes gene-silencing compounds like PH-762, targeting proteins such as PD-1, aimed at treating various cancers through intratumoral injections and adoptive cell therapy.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Phio Pharmaceuticals Corp.

1
1
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Reports $4M Net Loss and Increased R&D Expenses in Q1 2026

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Reports $8.7 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Reports $2.4 Million Net Loss in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Reports Q2 2025 Financial Results with Increased Net Loss and Rising Assets

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Reports Q1 2025 Financial Results, Highlights Increased Cash Position and Clinical Trial Progress

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Reports Financial Results, Raises Concerns Over Compliance and Funding

Via official filing (AI summary) | over 1 year ago | 0 comments